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P59 is the Trp-rich 20-mer peptide (767L–G786), partial sequence of the membrane-proximal external region (MPER) of the FIV gp36. It has
potent antiviral activity, possibly due to a mechanism that inhibits the fusion of the virus with the cell membranes. In the hypothesis that a
lipophilic tail could enhance the adhesion of P59 to the membrane so improving its antiviral activity, we synthesized its lipoylated analogue
lipo-P59. Fluorescence, CD and NMR investigations in membrane mimicking environments (such as SDS and DPC micelles) were aimed to
assess the potential of the lipo-P59 lipophilic tail to affect the biophysical and conformational behaviour of the peptide. In vitro inhibitory
assays using lymphoid cell cultures to check the antiviral activity of peptides were also performed. The data show that the biophysical
properties and the conformational preferences of the peptides are not dramatically affected by the hydrophobic tail, suggesting that the
lipopeptide is capable of preserving all the biophysical peculiarities. Similarly, antiviral experimental data show that the membrane-anchored
lipo-P59 peptide is also effective in inhibiting virus replication. Moreover, the lipophilic tail allows P59 to preserve its antiviral activity even in
conditions in which the non lipoylated peptide is devoid of activity. In accordance with the unusual high Trp presence, the peptides confirm the
preference to be positioned on the membrane interface. Furthermore, the data point out a peculiarity of interaction of the peptides with SDS as
compared with DPC.
© 2006 Elsevier B.V. All rights reserved.Keywords: FIV; Lipopeptide; Conformational analysis; Micelle interface1. Introduction
The feline immunodeficiency virus (FIV) is a naturally
occurring lentivirus that resembles the human immunodefi-
ciency virus (HIV) [1–4]. Much evidence suggests that FIVand
HIV perform cell entry via a common molecular mechanism
involving glycoproteins of the viral envelope and cell surface
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doi:10.1016/j.bbamem.2006.06.017and gp41, respectively, mediating the final event of membrane
fusion [5–7]. Despite the low sequence homology, gp36 and
gp41 exhibit a common structural framework and appear to play
similar roles in virus cell fusion [8–11].
A great deal of evidence shows that a structural switching of
TM glycoprotein is a key event for HIV infection. A
conformational transition toward an intermediate “pre-hairpin”
state favors the insertion of the hydrophobic amino-terminal
fusion peptide into the target cell membrane, eventually leading
to fusion [11,12].
The membrane-proximal external region (MPER) in the
ectodomain of the TM glycoprotein includes an unusual
clustering of triptophan residues conserved in numerous viral
1654 C. Esposito et al. / Biochimica et Biophysica Acta 1758 (2006) 1653–1661enveloped TM glycoproteins, indispensable to the function of
these glycoproteins [13–17]. Peptides deriving from the
carboxy-terminal ectodomain of the HIV TM glycoprotein are
able to prevent HIV cell membrane fusion [18–22], and one of
these, known as T-20 or enfuvirtide, which includes part of the
Trp-rich motif of the MPER in its C-terminus, is clinically used
as an anti HIV fusion inhibitor [23].
The Trp-rich motif of FIV consists of three equally
distanced Trp residues located at positions 770, 773, and 776
[24]. We recently synthesized a peptide corresponding to the
767L–G786 sequence of gp36. This peptide, that we named
P59, (LQKWEDWVGWIGNIPQYLKG) displayed antiviral
activity [25]. Furthermore, on testing deleted or substituted
peptides of P59, other analogues were found whose inhibitory
effects were shown to be dependent on the conservation of all
three Trp residues. There is enough evidence to hold that,
analogously to anti-HIV fusion inhibitors, P59 and its
analogues exert anti viral activity interacting with the TM
glycoprotein [26].
Chemically modified peptides carrying glyco- or lipo-
moieties are nowadays used for different purposes. They are
held to be endowed with improved membrane permeation
capabilities [27], or enhanced peptidase resistance [28]. In
immunology they promote immunogenicity through better
exposure to the cell surface [29]. Generally the main effect
required of the lipophilic tail of the lipopeptide is an
optimization of membrane adhesion [30]. However, these
conjugation reactions are never devoid of side effects, since
they may result in undesirable chemical and structural changes,
which could lead to a decrease in biological activity [31,32].
It has been recently demonstrated that membrane anchored
T20 is effective in its inhibitory action to a comparable degree to
that of the free peptide [33]. In the hypothesis that effective
interaction of P59 with the cell membrane surface could
enhance the fusion inhibitory activity, we synthesized the P59
lipoylated analogue (lipo-P59) bearing a lipophilic tail at the C-
terminus. Here, we report a combined study of P59 and its
lipoylated analog aimed to asses the relation between their
antiviral activity and conformational peculiarities, in particular
those depending on the lipophilic tail. Hence, biological assays
to check in vitro anti-FIVactivity in lymphoid cell cultures were
carried out. The biophysical and conformational behaviour of
P59 and lipo-P59 was investigated by means of several different
spectroscopic techniques, in amphiphilic systems mimicking
biological membranes, such as dodecylphosphocholine (DPC)
and sodium dodecyl sulphate (SDS) micelles.
2. Materials and methods
2.1. Peptide synthesis
The P59 (LQKWEDWVGWIGNIPQYLKG) peptide and its derivative
containing 2-aminooctadecanoic acid (Aod) at the C-terminal, lipo-P59
(LQKWEDWVGWIGNIPQYLK(Aod)), were manually synthesized on a
solid phase, using standard Fmoc/tBu chemistry. The TentaGel S RAM
(0.20 mmol/g capacity) resin was purchased from Fluka (Sigma Aldrich, Italy).
After deprotection of the 9-fluorenylmethoxycarbonyl (Fmoc) group with 30%
piperidine in N,N-Dimethylformamide (DMF), the amino acids in 4 fold excess
were coupled with the growing peptide chain, using DMF solution with anequimolar excess of 1-Hydroxybenzotriazole (HOBt) and 2-(1H-benzotriazol-1-
yl-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU). For the synthesis
of lipo-P59, the Fmoc-L-2-aminoctadecanoic acid (Fmoc-Aod-OH), from
EspiKem-Italy, was introduced by a double coupling as a standard amino
acid. All the reagents were from Novabiochem (France) or Sigma Aldrich
(Italy); other solvents and reagents used in peptide synthesis were obtained from
Sigma (Italy) or Carlo Erba (Italy) and used without further purification.
Peptide–resin cleavage and side chain deprotection reactions were carried out in
95% Trifluoroacetic acid (TFA), 2.5% water and 2.5% Triisopropylsilane (TIS).
After filtering to remove the resin followed by cold ether precipitation, the crude
peptides were recovered, kept in aqueous solution in order to completely remove
the Boc group from Trps, and lyophilized. Analytical RP-HPLC indicated a
>97% purity level. Finally, the peptides were characterized on a Finningan
LCQ-Deca ion trap instrument equipped with an electrospray source (LCQ Deca
Finnigan, San José. CA, U.S.A.); samples were directly infused in the ESI
source by using a syringe pump at the flow rate of 5 μl/min and spectra data were
analyzed using Xcalibur software.
2.2. Sample preparation
Fluorescence, Circular Dichroism (CD) and Diffusion Ordered Spectro-
scopy (DOSY) NMR experiments were performed in SDS and DPC solutions.
SDS and DPC were chosen as representatives of anionic and zwitterionic
micellar systems, respectively. The measurements include general titration with
surfactants starting from amounts of SDS and DPC much lower than the critical
micellar concentration (cmc), to concentrations largely higher than cmc.
2.3. Fluorescence titration measurements
Peptide–surfactant interactionswere studied bymonitoring the changes in the
Trp fluorescence emission spectra with increasing surfactant concentrations.
Fluorescence measurements were performed at 300 K using a LS 55
Luminescence Spectrofluorimeter (Perkin Elmer). The excitation wavelength
was 280 nm and emission spectra were recorded between 300 and 450 nm, at slit
widths of 5 nm. Titrations were performed by adding measured amounts of an
aqueous solution containing the peptide (3,5×10−5 M) and the surfactant at a
concentration well above the cmc to a weighed amount of an aqueous solution of
the peptide at the same concentration, initially put into the spectrofluorimetric
cuvette. In this way, the surfactant concentration was progressively increased,
while the peptide concentration remained constant during the whole titration.
After each addition there was a 20-min wait to ensure equilibrium had been
reached.
2.4. Circular dichroism
The peptide samples (150 μM) were prepared in a 25 mM phosphate buffer
solution (pH=7), in absence and in presence of SDS or DPC surfactants, at
premicellar and micellar concentrations. For micellar solutions, a 10 fold excess
surfactant concentration compared to cmc was used. Peptide concentrations were
estimated from the UVabsorption spectra at neutral pH using a 1-cm cell (Molar
absorpitivities of 5560M−1 cm−1 and 1200M−1 cm−1, at 280 nm, for Triptophan
and Tyrosine, respectively, were applied). CD spectra were performed on an 810-
Jasco spectropolarimeter at room temperature, using a quartz cuvette with a path
length of 1 mm. The spectra were the average of ten accumulations from 190 to
260 nm, recorded with a band width of 1 nm, at a scanning speed of 50 nm/min.
All the spectra were analyzed, subtracted by blanks and finally corrected by
smoothing. The estimation of the secondary structure composition was carried
out using the algorithm K2D by Dichroweb [34].
2.5. EPR measurements
EPR characterization of micellar aggregates in the presence and in the
absence of the biopeptides was performed using 5-doxylstearic acid and 16-
doxylstearic acid (5-DSA and 16-DSA, respectively, Sigma products) as spin
probes. The samples were prepared by weight and showed a surfactant
concentration 10 times higher than cmc and a spin probe concentration equal to
0.5 mM. The concentration of the peptide, if present, was 1 mM. The samples
Fig. 1. Tryptophan emission spectra (range 300–450 nm) of P59 (A) and lipo-
P59 (B) in aqueous buffer phosphate (unbroken line), in SDS (dotted line) and
DPC (dashed line) micellar solutions.
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a nitrogen atmosphere. EPR spectra were obtained using a Bruker ELEXYS
e500 X-band spectrometer. The instrument parameters were as follows:
modulation amplitude 0.16 G to avoid signal over modulation, time constant
1.28 ms, receiver gain 60 dB, microwave power 2 mW (20 dB) to prevent
saturation effects. All measurements were performed at room temperature. The
isotropic nitrogen hyperfine coupling constant and the correlation time of the
spin probes were obtained from the experimental spectra as described in a
previous work [35].
2.6. Self-diffusion experiments
NMR experiments were performed on a 600 MHz Bruker Avance
spectrometer. 1H NMR diffusion measurements were performed via a stimulated
echo sequence with bipolar gradient pulses [36]. The diffusion time (Δ) was set
to 100 ms. The pulsed gradients were increased from 2% to 95% of the
maximum strength in 16 spaced steps with a duration (δ/2) of 4 ms. Data were
acquired in aqueous solution of d25SDS/SDS (95:5) and d38DPC/DPC (95:5) at
pre-micellar and micellar concentrations. The temperature was maintained at
298 K to minimize convection effects.
2.7. FIV inhibition assay
Tests for virus inhibition were performed in 96-well flat-bottom microplates
against 10 50% tissue culture infectious doses (TCID50) of low-passage FIV-M2
isolate, using MBM cells as substrate and supernatant p25 antigen quantification
as an end point, exactly as previously described [26]. Briefly, 10 TCID50 of virus
was mixed with an equal volume of the test peptides diluted from 0.0005 to
50 μg/ml (final concentrations) in a culture medium (RPMI and 10% fetal bovine
serum), and immediately inoculated (100 μl/well) into 2 to 4 wells containing 105
MBM cells in 100 μl of culture medium. Alternatively, 10 TCID50 of virus was
inoculated into 2 to 4 wells containing 105 MBM cells previously pre-adsorbed
with test peptides diluted from 0.0005 to 50 μg/ml at 4 °C for 1 h, centrifuged at
600×g to remove peptide and re-suspended in 100 μl of culture medium. The
virus–peptide or virus-only inocula were rinsed out from the cultures after 5 h of
incubation at 37 °C. After 4 days, 100 μl of supernatant was removed from each
well and replaced with fresh medium. The cultures were stopped at day 8, when
p25 production by control wells in which virus infection was carried out in the
absence of peptide was well evident. Peptide inhibition of virus growth was
calculated using the formula (mean p25 concentration in wells inoculated with
FIV in presence of peptides/mean p25 concentration in wells inoculated with FIV
alone)×100. Fifty percent inhibitory concentrations (IC50) were calculated using
the predicted exponential growth function in Microsoft Excel as described
previously. Mean IC50±Standard Deviation were calculated using all replicates.
All experiments were repeated at least twice.
3. Results
3.1. Fluorescence titration measurements
The fluorescence intensities of some fine vibronic structures
in the tryptophan fluorescence spectrum show strong environ-
mental dependance [37,38]. In particular, the emission max-
imum shifts from 354 to 329 nm when going from water to an
apolar medium. The quantum yield could also undergo large
changes, the direction and extent of which depend on the system
under consideration [39].
To evaluate the influence of micellar environments on the
structural behaviour of P59 and lipo-P59, tryptophan fluores-
cence of both peptides in DPC and SDS micellar solutions was
registered. The spectra are shown in Fig. 1, where they are
compared with those in water. P59 in water (Fig. 1A) has a Trp
emission spectrum typical of the aqueous environment (λ-
max=354 nm), indicating that Trps are exposed to the aqueousmedium. Lipo-P59 in water (Fig. 1B) has a Trp emission
spectrum slightly shifted towards a lower wavelength (λ-
max=349 nm), suggesting that the Trps' exposure to solvent is
weakly but noticeably affected by the lipoylated tail. The
addition of DPC causes a change of the Trps quantum yield
which could be ascribed to peptide–micelle interaction [40].
Furthermore, the spectra are slightly shifted (λmax=347 nm for
P59 and λmax=343 nm for lipo-P59). The limited extent of the
shift indicates that the Trps are greatly exposed to the solvent,
suggesting a peptide positioning at the micelle surface rather
than inside the inner hydrophobic core. Also the addition of
SDS shifts the maximum of peptides spectra towards slightly
lower values (λmax=350 nm for P59 and λmax=340 nm for
lipo-P59), but the quantum yield change is much more limited
than with DPC and in the opposite direction. Interestingly, the
shift is more evident for lipo-P59, suggesting that the aliphatic
chain probably favours and stabilizes the interactions of the
peptide with SDS.
In order to obtain further information on peptide–surfactant
interaction, Trps fluorescence of both peptides was monitored at
surfactant concentrations ranging from premicellar to concen-
trated micellar solutions. Fig. 2A contains the variation of Trps
fluorescence for both peptides at λ=329 nm, corresponding to
the emission in a hydrophobic environment, with DPC
concentration. P59 and lipo-P59 display the same behaviour:
in dilute surfactant solutions, fluorescence intensity is similar to
that in water, indicating almost negligible interaction between
both peptides and DPC monomers. At the point of micelle
formation, a sharp fluorescence variation is observed, indicating
involvement of the peptides in the micellar environment. As a
matter of fact, the abrupt change in fluorescence occurs at a
Fig. 2. Trps fluorescence variation of P59 (full circle) and lipo-P59 (empty
circle) at λ=329 nm, with increasing DPC (A) and SDS (B) concentrations.
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concentration (cmc=0.001 mol kg−1), suggesting that the
peptides could somehow promote surfactant aggregation.
Fig. 2B shows the variation of Trps fluorescence at
λ=329 nm with SDS concentration. For both peptides, a very
low amount of surfactant is sufficient to induce dramatic
changes in the Trps fluorescence; moreover, no further change is
observed at the point of SDS micellization (cmc=0.008 mol
kg− 1). This evidence suggests that P59 and lipo-P59
interaction with SDS occurs with surfactant monomers rather
than with micelles.
The data in Fig. 2A and B offer the opportunity for a
quantification of the peptide–surfactant interaction. Actually,
the quantitative description of a peptide interaction with
biomembranes and related mimetic systems (vesicles,
micelles) has been the subject of recent scientific discussion
[41]. Two different approaches have been proposed: a
partition process and a binding mechanism. In the former, a
coefficient describing the mole-fraction partitioning of the
peptide between the solution bulk and the microscopically
dispersed hydrophobic phase, is defined as follows [42]:
Kp;x ¼
nP;M
nS
nP;W
nW
ð1Þ
where nS and nW are the moles of micellised surfactant and
water, respectively; nP,i is the number of moles of peptides
present in each phase (i=W, aqueous phase; i=M, micellar
phase).
In the binding approach, an association constant between the
peptide and the surfactant can be defined as follows [43]:
Ka ¼ ½PS½PF½SF ð2Þwhere [PS] is the concentration of a peptide–surfactant
complex; [PF] and [SF] are the concentrations of free peptide
and free surfactant, respectively. This model can be extended to
complexes formed by one peptide and n surfactant molecules.
Our experimental evidence suggests that it is not possible
to decide a priori which one of these two approaches is
correct. In fact, the partition approach well describes the
systems in which aspecific solubilization of the peptide in
micellar aggregates occurs, while a binding approach is
preferable when direct and specific interaction between the
peptide and surfactant molecules is found experimentally. In
the case of fluorescence data, in the partition approach the
variation of Trps fluorescence at λ=329 nm as surfactant
concentration varies is expected to show a sigmoidal trend
(as in the case of P59 and lipo-P59 with DPC), while in the
binding approach a saturation trend is expected (as in the
case of P59 and lipo-P59 with SDS).
Once the most representative model of a given system has
been chosen, interpolation of the experimental Trp fluorescence
data, F, by means of the proper equation allows the estimation
of the Kp,x value in the former approach, Ka and n in the latter.
In fact F is a population-weighed average between the value in
water, FW, and that in micelle (or in the peptide–surfactant
complex), FM. In the partition model, this can be written as:
F ¼ nP;W
nP
FW þ nP;MnP FM ð3Þ
where nP is the total number of peptide moles. Substitution of
Eq. (1) in Eq. (3) yields to:
F ¼ ðFM  FWÞKp;x
Kp;x þ nWnM
þ FW ð4Þ
The fitting of Eq. (4) to the experimental data allows the
evaluation of Kp,x.
In the equation for the binding approach, Trp fluorescence
can be expressed as:
F ¼ ½PF½PtotFW þ
½PS
½PtotFM ð5Þ
where [Ptot] is the total concentration of peptide. Eq. (2) can be
rearranged to the following quadratic equation [43]:
½PS2  ½PSð½Ptot þ ½Stot=nþ 1=nKaÞ þ ð½Stot=nÞ½Ptot ¼ 0
ð6Þ
where [Stot] is the total concentration of surfactant. The solution
to this quadratic equation is given by:
½PS ¼
n
AFðA2  4ð½Stot=nÞ½PtotÞ1=2
o
=2 ð7Þ
with
A ¼ ½Ptot þ ½Stot=nþ 1=nKa ð8Þ
Fig. 3. CD spectra of P59 (A) and lipo-P59 (B) in aqueous buffer phosphate
(unbroken line), in SDS premicellar (dotted line) and micellar (dashed line)
solutions.
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positive sign. Substitution of Eq. (7) in Eq. (5) yields to the
equation
F ¼ ðFM  FWÞfAþ ðA
2  4ð½Stot=nÞ½PtotÞ1=2g=2Þ
2½Ptot þ FW
ð9Þ
that can be fitted to the experimental data so allowing us to
estimate Ka and n.
Table 1 summarizes the Kp,x, Ka and n values obtained for
the systems under consideration. The Kp,x values obtained for
P59 and lipo-P59 in DPC micelles are quite high, showing that
both peptides tend to interact profoundly with DPC micelles.
The presence of the hydrophobic chain in the lipoylated
analogue does not seem to have a significant effect on the
solubilization process; indeed, the Kp,x value for lipo-P59 is
slightly lower than that evaluated for P59. The Ka and n values
obtained for P59 and lipo-P59 in DPC micelles show that both
peptides form complexes with about 5 SDS molecules with
quite a high binding constant; also in this case, the Ka value of
lipo-P59 is slightly lower than that of P59.
Because of the different models used for the two surfactants,
the Kp,x and Ka values are not easily comparable, the only
reasonable conclusion being that peptide–surfactant interaction
occurs through different mechanisms for the two surfactants. It
must be noted that the partition approach cannot be used in the
case of SDS, since it would require the assumption that the
surfactant cmc is null, which has no physical meaning. On the
other hand, using the binding approach to data in DPC produces
unsatisfactory results, since the model is not able to describe
sigmoidal trends.
3.2. CD experiments
CD measurements of the two peptides were performed in a
phosphate buffer (pH=7), and in solutions containing different
concentrations of SDS and DPC surfactants. As shown in Fig.
3A, in the buffer phosphate the P59 CD curve shows a
prevalence of random coil conformations, whereas the lipo-P59
(Fig. 3B) CD spectrum indicates an appreciable presence of
folded structures. Thus, the introduction of the hydrophobic tail
seems to favor a slightly more ordered conformation in the
aqueous environment.Table 1
Kp (partitioning coefficient between the solution bulk and the microscopically
dispersed hydrophobic phase), Ka (association constant between the peptide and
the surfactant), and n (number of surfactant molecules interacting with the
peptide), calculated for P59 and lipo-P59 in SDS and DPC micelle solutions
Kp,x×10
−5 Ka×10
−3 n
H2O-P59-DPC 3.6±0.8
H2O-P59-SDS 9.1±0.8 5±1
H2O-lipo-P59-DPC 2.3±0.5
H2O-lipo-P59-SDS 4.2±0.9 5±2In SDS and DPC micellar solutions, an increase in the helical
structure is observable for both peptides. In particular, in DPC
micelles both peptides clearly assume an alfa-helical conforma-
tion with the two typical minima at 209 nm and 220 nm (Fig. 4).
CD spectra of P59 and lipo-P59 were also recorded in SDS
and DPC surfactants in premicellar conditions. Whereas in SDS
solution (Fig. 3) the transition of the CD curves from a random
coil to the typical helical shape is already observable in the
presence of monomers, in DPC (Fig. 4), below cmc, the CD
spectra are very similar to those recorded in water solution.
These results confirm the fluorescence data, suggesting an
interaction between the peptides and the SDS monomers.
3.3. EPR analysis
To see whether the interaction of lipo-P59 with DPC and
SDS micelles influenced the micellar structure, we performed
EPR measurements on DPC and SDS micellar solutions
(mS≈10 cmc), in the absence and in the presence of the
peptide, using 5-doxylstearic acid (5-DSA) and 16-doxylstearic
acid (16-DSA) as spin probes [44,45]. The former provides
information on the micellar layer just below the external
surface, while the latter gives information on the interior of the
micellar hydrophobic core. The identity of all the recorded
spectra concerning the two peptides in both DPC and SDS
micellar systems with 5-and 1-doxyl-stearic acids indicated no
Table 2
Nitrogen coupling constant, and spin probe correlation time, measured by EPR
experiments on P59 and lipo-P59 in SDS and DPC micelle systems
5-DSA 16-DSA
〈AN〉/G τC×10
11/s 〈AN>/G τC×10
11/s
H2O-DPC 14.8 2.8 14.9 1.1
H2O-lipo-P59-DPC 14.7 2.6 15.0 1.3
H2O-SDS 15.6 8.2 15.4 4.7
H2O-lipo-P59-SDS 15.4 8.4 15.2 4.5
Fig. 4. CD spectra of P59 (A) and lipo-P59 (B) in aqueous phosphate buffer
(unbroken line), in DPC premicellar (dotted line) and micellar (dashed line)
solutions.
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nitrogen coupling constant, indicative of microenvironment
polarity, and the spin probe correlation time, indicative of
microenvironment viscosity, for all the samples under con-
sideration. Both parameters are almost unaffected by the
presence of lipo-P59, showing the structure of the micellar
aggregates to be unperturbed. This evidence suggests that,
despite the addition of the lipoylated tail, the peptide is
positioned close to the micellar surface, with very limited
intrusion into the hydrophobic inner core.
3.4. Self-diffusion measurements
The diffusion coefficients of lipo-P59 were measured on the
basis of NMR DOSY experiments at 600 mHz. The spectra
were recorded at a constant peptide concentration (1 mM) and at
two surfactant concentrations: the first at a concentration which
is nearly half the cmc, i.e. in the absence of micellar aggregates,
and the second at ten times cmc, i.e. in a rather concentrated
micellar solution. As a comparison, the self-diffusion coeffi-
cients of the two surfactants, DS, in premicellar solution in the
absence of the peptide were also measured. Below cmc the DPC
self-diffusion coefficient is only weakly affected by the peptide;
shifting from 0.33×10−9 m2 s−1 in the absence of lipo-P59 to
0.28×10− 9 m2 s− 1 in the presence of the lipopeptide.Furthermore, under these conditions Dlipo-59 (0.11×10
−9 m2
s−1) is very different from DS, indicating negligible interaction
between the two solutes. Above cmc, DS and Dlipo-59 (0.089
10−9 m2 s−1) assume the same level, coincident with the self-
diffusion coefficient of DPC micelles [46], thus indicating a
strong association of the peptide with the DPC micellar
aggregates. In the presence of SDS a quite different pattern of
behaviour is observed: below cmc, the SDS self-diffusion
coefficient significantly decreases from 0.49×10−9 m2 s−1 to
0.11×10−9 m2 s−1 because of the presence of the lipo-59,
suggesting that surfactant–peptide interaction takes place.
However, the mobility of the lipo-P59–SDS complex, as
measured by the peptide self-diffusion, is 0.083×10−9 m2 s−1
and thus higher than that of SDS micelles (∼0.052×109 m2
s−1) [47], suggesting that the interaction occurs between lipo-
P59 and SDS monomers.
From a quantitative point of view, self-diffusion data allow
us to estimate the number of SDS molecules associated to each
lipo-P59 molecule in the premicellar composition range. In fact,
the experimental DS is a population-weighted average of the
self-diffusion coefficients of free and bound SDS molecules,
DS,F and DS,B, according to the equation:
DS ¼ pFDS;F þ pBDS;B ð10Þ
where pF and pB are the fractions of free and bound SDS
molecules, respectively. DS,F can be assumed to be the same as
measured in the absence of the peptide, while DS,B is the
peptide self-diffusion coefficient. Consequently, Eq. (9) allows
us to estimate the amount of free and bound SDS molecules in
the sample. Under the reasonable assumption that all the peptide
molecules interact with the surfactant, the ratio between the
concentration of bound SDS molecules and that of the peptide
gives an estimation of the number of SDS molecules bound to
each lipo-P59 molecule, which was found to be ∼4, in close
agreement with the value obtained from fluorescence
measurements.
Above cmc, DS and Dlipo-59 are at the same level and equal
to the diffusion coefficients of SDS micelles, thus indicating
strong association of the peptide with SDS micellar aggregates.3.5. Antiviral assay
To investigate on the lipophilic tail's ability to affect P59
antiviral activity, P59 and lipo-P59 were tested for their
inhibitory activity on FIV replication as reported elsewhere
[26]. Biological tests show that IC50 of P59 and lipo-P59
Table 3
Inhibition of a primary FIV-M2 isolate replication by peptide 59 and lipo-59
Expt
no. a
Mean IC50±SD (μg/ml) of peptide
P59 lipo-P59 Control b
1 0.06±0.01 0.08±0.02 >50
2 >50 0.74±0.04 >50
a In experiment 1 the antiviral activity of the synthetic peptides was assayed
for inhibition of FIV replication by the standard procedure (26). In experiment 2,
aimed at checking peptide inhibitory activity adsorbed onto cell substrate, the
synthetic peptides were pre-incubated with MBM cells at 4 °C for 1 h. Then the
MBM cells were centrifuged at 600×g for 15 min (to remove peptides),
inoculated with virus and assayed for inhibition of the FIV. The experiment was
repeated three times with comparable results. IC50, 50% inhibitory
concentration.
b A 20-mer control peptide derived from a different region of the FIV TM.
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for peptide P59 and lipo-P59, respectively) when both
peptides were mixed with virus and immediately inoculated
into an MBM cell substrate. Conversely, when the peptides
were pre-incubated with substrate cells and washed out by
centrifugation prior to virus addition, the lipoylated analog
lipo-P59 maintained a substantial antiviral activity whereas
P59 was shown to be completely inactive. A 20-mer control
peptide derived from a different region of the FIV TM was
devoid of activity. Furthermore, peptides P59 and lipo-P59
had no detectable effects on MBM cell viability and
proliferation (data not shown).
4. Discussion
P59 is the Trp-rich 20-mer peptide (767L–G786) derived
from the MPER of the FIV gp36. Much evidence suggests
that, in analogy with HIV cell entry, the TM glycoprotein
plays a crucial role in the conformational arrangements
leading to the fusion of FIV and cell membranes [10–12]. In
particular, the MPER seems determinant for the induction and
the stabilization of the conformational state preceding viral
and cell membrane fusion [10,11,16,17]. Recently, it has been
shown that P59 has potent antiviral activity [25]. As with
HIV fusion inhibitors, it has been supposed that the P59
inhibitory mechanism could involve interaction with an as yet
unidentified domain of gp36 most likely located in the N-
terminus in a structural state for which membrane proximity
could be a determining factor [26].
To enhance HIV antiviral activity, the expression of a
membrane-anchored TM glycoprotein derived peptide has been
recently carried out [33]. In the hypothesis that a lipophilic tail
could enhance the adhesion of P59 to the membrane, increasing
its antiviral activity, we synthesized its lipoylated analogue lipo-
P59. Fluorescence, CD and NMR data in membrane mimicking
environments were collected to explore solvent exposure
properties and conformational preferences both in P59 and
lipo-P59. The aim of the work was to assess the potential of the
lipo-P59 lipophilic tail to affect biological functionality as a
consequence of a modified biophysical and conformational
behaviour of the peptide.Antiviral assays showed that lipo-P59 effectively inhibits
FIV replication as well as P59. Furthermore, differently from
P59, it maintains its activity when it is membrane-anchored. The
latter finding could most likely depend upon more effective
interaction of the lipoylated peptide as compared to the non
lipoylated one.
As membrane mimetics, we chose SDS and DPC micellar
solutions. Since SDS and DPC are anionic and zwitterionic
surfactants, respectively, they allowed us to evaluate the
contribution of electrostatic and hydrophobic forces in pep-
tide/micelle interactions.
Trp fluorescence emission spectra of P59 and lipo-P59 in
water are typical of water exposed molecules whenever lipo-
P59 shows to be weakly, but noticeably, affected by the
lipoylated tail. This suggests that in an aqueous environment the
lipophilic tail is folded toward the Trp residues, inducing the
presence of a more hydrophobic environment. In the presence of
increasing amounts of DPC and SDS no evidence of peptide
internalization into the micelles is observable, confirming a
tendency of the Trp rich fragments to be positioned at the
micelle surface rather than inside the inner hydrophobic core.
Furthermore whereas the interaction of P59 and lipo-P59 takes
place with DPC micellar surface, a contact of the peptides with
monomeric SDS results evident. It can be quantitatively
estimated that about five SDS monomers interact with each
peptide molecule. The peptide–SDS monomer interaction is
confirmed by the NMR DOSY experiments which show a
decreasing of the diffusion coefficient relative to SDS–peptide
complex even at SDS concentrations much lower than cmc. On
the contrary, DPC molecules and lipo-P59 have separate
diffusion coefficients below cmc, assuming a unique, signifi-
cantly lower diffusion coefficient when the DPC micelles are
formed and the peptides interact with them. In fluorescence
experiments, lipo-P59 in SDS shows the capability of the
aliphatic chain to promote a more compact structure of the
peptide–SDS complex. However, computed partition coeffi-
cients indicate that the aliphatic chain does not significantly
affect the strength of the peptide–surfactant binding.
The conformational behaviour of P59 and its lipoylated
analogue was explored by CD spectroscopy. In accordance to
the fluorescence data, in water, the CD spectra of P59 and lipo-
P59 point out the ability of lipo-P59 lipophilic tail to affect the
conformational preference of the lipo-peptide by folding the
hydrophobic chain towards the backbone. In the presence of
DPC and SDS micelle solutions, P59 and lipo-P59 undergo to
conformational transition resulting in a prevalence of helical
structures, highlighting the ability of the membrane mimicking
environment to promote a helical ordered conformation for both
the peptides. Consistently with the previously mentioned
spectroscopic data, the structure stabilizing effect is mediated
by SDS even in monomeric state, whereas it requires DPC in
micellar state.
To sum up, the reported data show that the aliphatic chain
allows P59 to preserve its antiviral activity even in conditions in
which the non lipoylated peptide is devoid of activity . This
result can be ascribed to an enhanced interaction of lipo-P59
with the plasma membrane compared to P59, most likely
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action. Hence, it is interesting to observe that the biophysical
properties and the conformational preferences of the peptides
are not dramatically affected by the lipophilic tail, suggesting
that the lipopeptide has the capability to preserve all the
biophysical characteristics.
Furthermore, our study has highlighted the importance of the
choice of membrane mimicking systems used in biological
research. In fact, SDS and DPC interact in different ways with
our peptides, leading to formulate new hypotheses on the
dynamic of interaction between bio-molecules and different
surfactants. In particular, the dynamic of aggregation of our
peptides with SDS monomers suggests a mechanism of
surfactant interaction, in which the peptides can work as starter
of micelle formation. The process should be triggered by a
hydrophobic interaction between the hydrophobic portion of the
peptides and the lipophilic tails of SDS detergent. Synergisti-
cally, the SDS–peptide contact is stabilized by an electrostatic
interaction occurring between the strongly negative head-
groups of SDS and the positive side chains of lysines, which
are present in the extremities of the P59 sequence. On the
contrary, in DPC solution the peptides seem to be not involved
in the process of micelle formation, probably due to the limited
stabilizing electrostatic interaction with the zwitterionic head-
groups. Thus, the micelle formation seems to occur indepen-
dently than the presence of the peptides which show to have
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